LUTS, lower urinary tract symptoms QoL, quality of life; QoL can be regarded as covering bothersomeness, impact on quality of life, and sexual functioning BPH, benign prostatic hyperplasia; this term is reserved for the characteristic histological changes associated with BPH BPE, benign prostatic enlargement; this term refers to documented enlargement of the gland BPO, benign prostatic obstruct...

Introduction: Prostate cancer is the second common malignancy in men. Prostatic intraepithelial neoplasia (PIN) precursor lesion of prostatic carcinoma. Histopathological examination necessary to diagnose PIN lesions. Objective: The aim study determine incidence and analyse usefulness basal cell marker p63 expression various lesions prostate. Methods: This a two-year prospective 65 transurethra...

Prostatic hyperplasia (PH) is a common urologic disease that affects mostly elderly men. PH can be classified as benign prostatic hyperplasia (BPH), or prostate cancer (PCa) based on its severity. Oxidative stress (OS) is known to influence the activities of inflammatory mediators and other cellular processes involved in the initiation, promotion and progression of human neoplasms including pro...

BACKGROUND A single nucleotide variation within catechol-o-methyl transferase (COMT) gene may alter the COMT enzyme activity level. Polymorphism of Val158Met in the COMT gene has been related to malignancy. In this regard, a study was carried out to find a possible association between the COMT gene polymorphism in patients with sporadic prostate cancer (PCa) and benign prostatic hyperplasia (BP...

In 1788 John Hunter first described the pathology of prostatic hyperplasia and its effects on the upper urinary tract. It took a century for the first suprapubic prostatectomy to be carried out in 1887 by AF McGill in Leeds (though Americans tend to claim credit to Fuller in New York in 1894.) The procedure was subsequently p o p u l a r i s e d b y S i r Pe t e r F r e ye r . R e t r o p u b i...

Benign prostatic hyperplasia (BPH) is a benign hyperplasia of prostate gland cells of the urethra affecting increasing population. The most common method of treatment is transurethral resection of the prostate (TURP). But many complications may occur including intraoperative or postoperative hemorrhage, prostate perforation, urinary incontinence and bladder neck contracture. Transurethral ballo...

BACKGROUND Phytotherapy is a popular treatment option in cases of benign prostatic hyperplasia (BPH), with many different herbal products being used for the treatment of this condition. Withania coagulans (WC) is an herbal medicine that has shown anti-tumoral, anti-inflammatory, and antioxidant effects. OBJECTIVES This study examined the effect of Withania coagulans extract (WCE) on prostatic...

Aim: To evaluate the association between male pattern baldness (MPB) and benign prostatic hyperplasia (BPH).
 Methodology: Cohort study, data collected by co-authors. All extracted were input to Excel sheets further imported into STATA version 14. The study’s results reported in form of descriptive statistics.
 Results: This study found no significant associations MPB BPH. Nonetheless...